Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
PTHS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -50.1%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
pelthos
therapeutics
2025
topical
xeglyze
announced
million
board
directors
appointment
einhorn
revenue
abametapir
treatment
head
lice
acquisition
approved
royalty
andrew
PTHS
Pelthos Therapeutics Inc.